Mon MB, Murray T, Thun M: Cancer statistics, 2001. CA Cancer J

Mon MB, Murray T, Thun M: Cancer statistics, 2001. CA Cancer J Clin 2001, 51:156. 2. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, Sesterhenn IA, Tachibana M, Weider J: Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005, 66:44. three. Van Brussel JP, Mickisch GH: Prognostic components in renal cell and bladder cancer. BJU Int 1999, 83:90208. quiz 90809. four. Harvey KF, Pfleger CM, Hariharan IK: The Drosophila Mst ortholog, hippo, restricts development and cell proliferation and promotes apoptosis. Cell 2003, 114:45767. five. Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N, Ho LL, Li Y: Handle of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 2005, 120:67585. six. Edgar BA: From cell structure to transcription: Hippo forges a brand new path.Kynurenic acid Inducer Cell 2006, 124:26773. 7. Hariharan IK, Bilder D: Regulation of imaginal disc growth by tumorsuppressor genes in Drosophila. Annu Rev Genet 2006, 40:33561. eight. Harvey K, Tapon N: The Salvador-Warts-Hippo pathway – an emerging tumour-suppressor network. Nat Rev Cancer 2007, 7:18291. 9. Sudol M: Yes-associated protein (YAP65) is really a proline-rich phosphoprotein that binds towards the SH3 domain with the Yes proto-oncogene product.SecinH3 Epigenetics Oncogene 1994, 9:2145152. 10. Bork P, Sudol M: The WW domain: a signalling site in dystrophin Trends Biochem Sci 1994, 19:53133.PMID:35954127 11. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW: Identification and validation of oncogenes in liver cancer utilizing an integrative oncogenomic strategy. Cell 2006, 125:1253267. 12. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, Deng CX, Brugge JS, Haber DA: Transforming properties of YAP, a candidate oncogene around the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 2006, 103:124052410. 13. Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R, Schoenmakers EF, Massimino M, Sozzi G: Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical traits. J Clin Oncol 2006, 24:5223233. 14. Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D, Montgomery EA, Anders RA: Expression of Yes-associated protein in typical solid tumors. Hum Pathol 2008, 39:1582589. 15. Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT, Zender L, Lowe SW, Poon RT, Luk JM: Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 2009, 115:4576585. 16. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, Zheng P, Ye K, Chinnaiyan A, Halder G, Lai ZC, Guan KL: Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell get in touch with inhibition and tissue development handle. Genes Dev 2007, 21:2747761. 17. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D: Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120133. 18. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, Brummelkamp TR: YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007, 17:2054060. 19. Greene FL, Web page DL, Fleming ID, April F, Balch CM, Haller DG, Monica M: American Joint Committee on Cancer (AJCC) staging manual. 6th edition. Philadelphia: Springer; 2002. 20. Xie D, Sham JS, Zeng WF,.